407 related articles for article (PubMed ID: 18243862)
1. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
Bettencourt P; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
[TBL] [Abstract][Full Text] [Related]
2. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
Masson S; Latini R
Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
[TBL] [Abstract][Full Text] [Related]
5. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
Troughton RW; Richards AM
Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863
[TBL] [Abstract][Full Text] [Related]
6. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):43-8. PubMed ID: 18243858
[TBL] [Abstract][Full Text] [Related]
7. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations.
van Kimmenade RR; Pinto YM; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):39-42. PubMed ID: 18243857
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients.
Johns MC; Stephenson C
Am J Cardiol; 2008 Feb; 101(3A):76-81. PubMed ID: 18243864
[TBL] [Abstract][Full Text] [Related]
9. Amino-terminal pro-B-type natriuretic peptides in stable and unstable ischemic heart disease.
Omland T; de Lemos JA
Am J Cardiol; 2008 Feb; 101(3A):61-6. PubMed ID: 18243861
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
11. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients.
Hildebrandt P; Collinson PO
Am J Cardiol; 2008 Feb; 101(3A):25-8. PubMed ID: 18243854
[TBL] [Abstract][Full Text] [Related]
13. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients.
Pascual-Figal DA; Domingo M; Casas T; Gich I; Ordoñez-Llanos J; Martínez P; Cinca J; Valdés M; Januzzi JL; Bayes-Genis A
Eur Heart J; 2008 Apr; 29(8):1011-8. PubMed ID: 18263871
[TBL] [Abstract][Full Text] [Related]
15. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
[TBL] [Abstract][Full Text] [Related]
16. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
17. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
18. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
[TBL] [Abstract][Full Text] [Related]
19. Understanding amino-terminal pro-B-type natriuretic peptide in obesity.
Bayes-Genis A; DeFilippi C; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):89-94. PubMed ID: 18243866
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
